Pharma Pulse: US Exits the World Health Organization; Hospitals Overwhelmed by Historic Flu Crisis
Pharma Pulse: Federal Funding Averts Shutdown and Pfizer’s Adjuvant Play
Pharma Pulse: Industry Backlash, GSK’s $2.2B Immunology Bet, and the Future of Wearables
Pharma Pulse: Global AI Alignment, the TrumpRx Pivot, and Nano-Delivery GLP-1s
Pharma Pulse: Novartis Warns of Trade Fragmentation; Hospital M&A Hits Record Low; Copay Shock Warning
Pharma Pulse: Trump’s New Healthcare Roadmap, FDA Vaccine Warnings, and BPD to Lead The Agency Network
Pharma Pulse: Navigating the New Era of Healthcare
Pharma Pulse: Precision Cancer Care
Pharma Pulse: Amazon Pharmacy Sells Oral Wegovy, J&J’s Billion-Dollar Hub, and the Debt-Housing Crisis
Pharma Pulse: J&J Enters TrumpRx and the Red Flags in Pediatric Vaccines
Pharma Pulse: Merger Fever, Lilly’s $1.2B Inflammatory Bet, and the Birth of CareTria
Pharma Pulse: FDA Fast-Tracks Merck Blockbusters, GSK’s Precision Data Bet, and DHL’s Massive PA Hub
Pharma Pulse: Pediatric Vaccine Revisions, COPD Mortality Trends, and Eli Lilly’s $1.3B Obesity Deal
Pharma Pulse: GoodRx Rollout for Oral Wegovy; Major Reprieve for 340B Hospitals; Sanofi’s $2.5B AI Bet
Pharma Pulse: FDA Ends 40-Year Drought for Motion Sickness
Pharma Pulse: A Win for Bone Health
Pharma Pulse: FDA Clears First Oral Wegovy; Yusen Logistics Seals European Health Deal
Pharma Pulse: US Manufacturing Expansion, Oncology Partnerships, and Workplace Health
Pharma Pulse: TrumpRx Gains Nine New Pharma Partners; DHL Expands LAX Cold Chain Hub
Pharma Pulse: Navigating the Biosecure Act, Post-Viral Sleep Phenotypes, and Rising Insurance Costs
Pharma Pulse: The ACA Subsidy Cliff and New Frontiers for GLP-1s
Pharma Pulse: Onshoring Investments and the AI Frontier
Pharma Pulse: SOBI’s $1.5B Gout Acquisition Clears Pipeline; New Cholesterol Drug Lerochol Scores on Convenience
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial
Pharma Pulse: FDA Fast-Tracks Antibiotic Approval, as Protected EHR Time Combats Physician Burnout
Pharma Pulse: FDA Shifts CAR-T Standards and Maryland Expands Medical Class Size, as Pharma Channels Brace for Massive Patent Cliff Disruption
Pharma Pulse: Lilly’s Jaypirca Challenges Imbruvica, as AI Chatbots Could Prove Key to Boosting Vaccine Rates
Pharma Pulse: ACIP Ends Universal Hep B Birth Dose
Pharma Pulse: New CDER Director Appointed, as Medicaid Shows Potential to Save Cancer Lives
Pharma Pulse: Pazdur Retires from FDA, While Public Trusts AMA Over CDC on Vaccines, and New Data Redefines Adherence as an Emotional Crisis
Pharma Pulse: Long COVID Exercise Win, $150M Gene Editing Play, and Compounding Pharmacy Expansions
Pharma Pulse: US-UK Trade Deal Forces Pricing Shift, as Lilly Deepens GLP-1 Price Cuts and RSV-Asthma Link Confirmed
Pharma Pulse: Medicare Price Cuts and Vaccine Wins
Pharma Pulse: Medicare Price Negotiations Heat Up, as FDA Approves SMA Gene Therapy
Pharma Pulse: RSV Protection Wanes, AstraZeneca Invests Big, and Novo Nordisk Faces Pipeline Setback
Pharma Pulse: AI Drug Discovery Hits Billion-Dollar Scale, as Abbott Is Set to Acquire Diagnostics Giant
Pharma Pulse: Long COVID's Enduring Challenge Amid Major US Manufacturing Surge
Pharma Pulse: Regulatory Crucible, China Supply Risk, and Texting Triumphs in Diabetes Care
Pharma Pulse: Patients Struggle to Identify Safe Online Pharmacies, as Novo Nordisk Launches Access Offers
Pharma Pulse: Rural Vaccine Gaps, Semaglutide Organ-Protective Benefits, and Amazon Pharmacy’s Urgent Care Expansion Shape Healthcare Outlook
Pharma Pulse: Young Adults Skip Cholesterol Care, as Pharmacy Access Gaps Widen and Crypto Enters the Prescription Market
Pharma Pulse: FDA Advances New Approval Pathway, as Obesity Care and Metabolic Treatments Gain Momentum
Pharma Pulse: FDA Appoints Richard Pazdur as CDER Director Amid 340B Tensions and Novartis Expansion
Pharma Pulse: HHS Updates Menopausal Hormone Therapy Labels, as SGLT2 Inhibitors Show Broader Kidney and Heart Benefits
Pharma Pulse: New Research and Policy Moves Shape Pharma Landscape
Pharma Pulse: FDA Expands Priority Voucher Program, as Oral Semaglutide Shows New Benefits and Cost Plus Drugs Adds Starjemza
Pharma Pulse: Novartis Buys Avidity for $12B, and Trump Threatens 10% Tariff Hike on Canada
Pharma Pulse: Cholesterol Imbalance Tied to Depression Risk, Lilly Acquires Aderum Biotechnologies, and Cambrex Expands API Manufacturing
Pharma Pulse: Alkermes Acquires Avadel in $2.1B Deal, BioNTech Moves to Buy CureVac, and MedTech Industry Embraces Digital-First Models
next page